Annual Net Income
-$13.98 M
+$11.75 M+45.67%
December 31, 2023
Summary
- As of February 24, 2025, POAI annual net profit is -$13.98 million, with the most recent change of +$11.75 million (+45.67%) on December 31, 2023.
- During the last 3 years, POAI annual net income has risen by +$11.90 million (+45.98%).
- POAI annual net income is now -933.78% below its all-time high of -$1.35 million, reached on December 31, 2010.
Performance
POAI Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$3.09 M
+$86.60 K+2.72%
September 30, 2024
Summary
- As of February 24, 2025, POAI quarterly net profit is -$3.09 million, with the most recent change of +$86.60 thousand (+2.72%) on September 30, 2024.
- Over the past year, POAI quarterly net income has stayed the same.
- POAI quarterly net income is now -311.23% below its all-time high of $1.47 million, reached on June 30, 2019.
Performance
POAI Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$13.97 M
+$68.80 K+0.49%
September 30, 2024
Summary
- As of February 24, 2025, POAI TTM net profit is -$13.97 million, with the most recent change of +$68.80 thousand (+0.49%) on September 30, 2024.
- Over the past year, POAI TTM net income has stayed the same.
- POAI TTM net income is now -3021.81% below its all-time high of -$447.50 thousand, reached on September 30, 2008.
Performance
POAI TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
POAI Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +45.7% | 0.0% | 0.0% |
| 3 y3 years | +46.0% | +21.1% | +27.7% |
| 5 y5 years | -38.6% | +21.1% | +27.7% |
POAI Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +45.7% | at high | +70.2% | at high | +48.2% |
| 5 y | 5-year | at high | +46.0% | -20.2% | +77.2% | at high | +50.0% |
| alltime | all time | -933.8% | +46.0% | -311.2% | +77.2% | -3021.8% | +50.0% |
Predictive Oncology Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$3.09 M(-2.7%) | -$13.97 M(-0.5%) |
| Jun 2024 | - | -$3.18 M(-24.6%) | -$14.04 M(-5.0%) |
| Mar 2024 | - | -$4.22 M(+21.4%) | -$14.78 M(+5.7%) |
| Dec 2023 | -$13.98 M(-45.7%) | -$3.48 M(+9.9%) | -$13.98 M(-24.1%) |
| Sep 2023 | - | -$3.16 M(-19.4%) | -$18.42 M(-4.6%) |
| Jun 2023 | - | -$3.92 M(+14.7%) | -$19.32 M(-25.1%) |
| Mar 2023 | - | -$3.42 M(-56.8%) | -$25.79 M(+0.2%) |
| Dec 2022 | -$25.74 M(+30.9%) | -$7.92 M(+95.0%) | -$25.74 M(+0.6%) |
| Sep 2022 | - | -$4.06 M(-60.9%) | -$25.58 M(-5.1%) |
| Jun 2022 | - | -$10.39 M(+208.3%) | -$26.96 M(+40.8%) |
| Mar 2022 | - | -$3.37 M(-56.5%) | -$19.14 M(-2.6%) |
| Dec 2021 | -$19.66 M(-24.1%) | -$7.76 M(+42.6%) | -$19.66 M(-15.9%) |
| Sep 2021 | - | -$5.44 M(+111.3%) | -$23.37 M(-3.6%) |
| Jun 2021 | - | -$2.57 M(-33.8%) | -$24.24 M(-4.0%) |
| Mar 2021 | - | -$3.89 M(-66.1%) | -$25.24 M(-2.5%) |
| Dec 2020 | -$25.88 M(+33.5%) | -$11.47 M(+81.8%) | -$25.88 M(-7.5%) |
| Sep 2020 | - | -$6.31 M(+76.3%) | -$27.97 M(+9.0%) |
| Jun 2020 | - | -$3.58 M(-21.0%) | -$25.67 M(+24.4%) |
| Mar 2020 | - | -$4.53 M(-66.6%) | -$20.63 M(+6.4%) |
| Dec 2019 | -$19.39 M(+92.2%) | -$13.55 M(+238.1%) | -$19.39 M(+108.9%) |
| Sep 2019 | - | -$4.01 M(-373.6%) | -$9.28 M(+19.3%) |
| Jun 2019 | - | $1.47 M(-144.5%) | -$7.78 M(-33.0%) |
| Mar 2019 | - | -$3.29 M(-4.4%) | -$11.62 M(+15.2%) |
| Dec 2018 | -$10.09 M(+68.0%) | -$3.45 M(+37.5%) | -$10.09 M(+29.9%) |
| Sep 2018 | - | -$2.51 M(+5.6%) | -$7.77 M(+24.2%) |
| Jun 2018 | - | -$2.37 M(+34.9%) | -$6.25 M(-2.7%) |
| Mar 2018 | - | -$1.76 M(+56.4%) | -$6.42 M(+7.0%) |
| Dec 2017 | -$6.00 M(-8.0%) | -$1.13 M(+13.4%) | -$6.00 M(+7.0%) |
| Sep 2017 | - | -$992.10 K(-61.0%) | -$5.61 M(-1.1%) |
| Jun 2017 | - | -$2.54 M(+89.6%) | -$5.67 M(-0.3%) |
| Mar 2017 | - | -$1.34 M(+83.1%) | -$5.69 M(-12.8%) |
| Dec 2016 | -$6.53 M | -$732.80 K(-30.6%) | -$6.53 M(-19.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2016 | - | -$1.06 M(-58.8%) | -$8.06 M(-0.7%) |
| Jun 2016 | - | -$2.56 M(+17.7%) | -$8.12 M(+20.4%) |
| Mar 2016 | - | -$2.18 M(-3.8%) | -$6.74 M(+40.7%) |
| Dec 2015 | -$4.79 M(-29.9%) | -$2.26 M(+102.7%) | -$4.79 M(-2.1%) |
| Sep 2015 | - | -$1.12 M(-5.8%) | -$4.89 M(+0.0%) |
| Jun 2015 | - | -$1.19 M(+424.9%) | -$4.89 M(-10.1%) |
| Mar 2015 | - | -$225.80 K(-90.5%) | -$5.44 M(-20.4%) |
| Dec 2014 | -$6.83 M(-27.4%) | -$2.37 M(+112.1%) | -$6.83 M(+3.2%) |
| Sep 2014 | - | -$1.12 M(-35.8%) | -$6.62 M(-30.2%) |
| Jun 2014 | - | -$1.74 M(+7.4%) | -$9.48 M(+6.3%) |
| Mar 2014 | - | -$1.62 M(-24.9%) | -$8.92 M(-5.2%) |
| Dec 2013 | -$9.41 M(+26.7%) | -$2.15 M(-45.8%) | -$9.41 M(+4.9%) |
| Sep 2013 | - | -$3.97 M(+238.1%) | -$8.97 M(+14.3%) |
| Jun 2013 | - | -$1.18 M(-44.1%) | -$7.85 M(-10.9%) |
| Mar 2013 | - | -$2.10 M(+22.4%) | -$8.81 M(+18.7%) |
| Dec 2012 | -$7.42 M(+65.4%) | -$1.72 M(-39.9%) | -$7.42 M(-14.4%) |
| Sep 2012 | - | -$2.86 M(+33.7%) | -$8.67 M(+34.0%) |
| Jun 2012 | - | -$2.14 M(+199.4%) | -$6.47 M(+37.0%) |
| Mar 2012 | - | -$713.40 K(-76.0%) | -$4.72 M(+5.3%) |
| Dec 2011 | -$4.49 M(+231.7%) | -$2.97 M(+353.7%) | -$4.49 M(+134.2%) |
| Sep 2011 | - | -$654.10 K(+68.5%) | -$1.92 M(+34.9%) |
| Jun 2011 | - | -$388.10 K(-18.7%) | -$1.42 M(+31.7%) |
| Mar 2011 | - | -$477.40 K(+20.4%) | -$1.08 M(-20.3%) |
| Dec 2010 | -$1.35 M(-53.2%) | -$396.50 K(+150.8%) | -$1.35 M(+1.5%) |
| Sep 2010 | - | -$158.10 K(+239.3%) | -$1.33 M(-31.6%) |
| Jun 2010 | - | -$46.60 K(-93.8%) | -$1.95 M(-26.2%) |
| Mar 2010 | - | -$751.50 K(+99.4%) | -$2.64 M(-8.8%) |
| Dec 2009 | -$2.89 M(+64.1%) | -$376.80 K(-51.3%) | -$2.89 M(-13.0%) |
| Sep 2009 | - | -$773.00 K(+4.9%) | -$3.32 M(+10.9%) |
| Jun 2009 | - | -$737.00 K(-26.7%) | -$3.00 M(+32.6%) |
| Mar 2009 | - | -$1.01 M(+24.6%) | -$2.26 M(+80.1%) |
| Dec 2008 | -$1.76 M | -$807.30 K(+80.4%) | -$1.25 M(+180.4%) |
| Sep 2008 | - | -$447.50 K | -$447.50 K |
FAQ
- What is Predictive Oncology annual net profit?
- What is the all time high annual net income for Predictive Oncology?
- What is Predictive Oncology annual net income year-on-year change?
- What is Predictive Oncology quarterly net profit?
- What is the all time high quarterly net income for Predictive Oncology?
- What is Predictive Oncology quarterly net income year-on-year change?
- What is Predictive Oncology TTM net profit?
- What is the all time high TTM net income for Predictive Oncology?
- What is Predictive Oncology TTM net income year-on-year change?
What is Predictive Oncology annual net profit?
The current annual net income of POAI is -$13.98 M
What is the all time high annual net income for Predictive Oncology?
Predictive Oncology all-time high annual net profit is -$1.35 M
What is Predictive Oncology annual net income year-on-year change?
Over the past year, POAI annual net profit has changed by +$11.75 M (+45.67%)
What is Predictive Oncology quarterly net profit?
The current quarterly net income of POAI is -$3.09 M
What is the all time high quarterly net income for Predictive Oncology?
Predictive Oncology all-time high quarterly net profit is $1.47 M
What is Predictive Oncology quarterly net income year-on-year change?
Over the past year, POAI quarterly net profit has changed by $0.00 (0.00%)
What is Predictive Oncology TTM net profit?
The current TTM net income of POAI is -$13.97 M
What is the all time high TTM net income for Predictive Oncology?
Predictive Oncology all-time high TTM net profit is -$447.50 K
What is Predictive Oncology TTM net income year-on-year change?
Over the past year, POAI TTM net profit has changed by $0.00 (0.00%)